INCITE Attracts Another ‘Superstar,’ Adds Might to Precision Health

Posted: Updated:
Dr. Chandan Sen is the latest scientist recruited by the INCITE program. Dr. Chandan Sen is the latest scientist recruited by the INCITE program.

The Indiana University Precision Health Initiative (PHI), now at the two-year mark, recently announced progress toward its goal to unleash the power of personalized medicine to cure one cancer and one childhood disease over the next decade. One engine driving that machine is the human talent that has been recruited to the state, supported by a $25 million INCITE grant. The Lilly Endowment Inc. funds aim to link the scientists to the business sector and spur translational research. The number of these “superstar” scientists is growing, and leaders say the business benefits are certain to follow.

“INCITE allows the IU School of Medicine (IUSM) to bring talent to Indy that are desired also by the public sector—that’s the real purpose of INCITE,” says PHI Principal Investigator and IU Associate Vice President for Clinical Affairs Dr. Anantha Shekhar. “We’ve leveraged the PHI and INCITE programs—combined the two opportunities, so we can really go after superstars, as opposed to one source helping us recruit good talent, but not superstar talent.”

The INCITE program, announced one year ago, aims to hire 10 prominent scientists who are renowned in their field. Three have already joined the forces at IU. The latest was announced just this month: Dr. Chandan Sen will oversee IUSM’s Indiana Center for Regenerative Medicine and Engineering.

He joins INCITE scientists Dr. Michael Weiss, who is creating better insulins for patients with diabetes, and Dr. Roland Herzog, an immunologist developing a variety of innovative programs for children’s diseases. Shekhar says IUSM will announce a fourth scientist soon, who is a prominent expert in asthma and childhood diseases.

“That will transform our ability to do pediatric research at Riley [Hospital for Children at IU Health] and will be a close collaboration with Lilly,” says Shekhar. “He will be very much responsible for the [PHI] childhood disease pillar and hopefully will bring some new areas as well, in terms of closer partnership with Lilly and Riley.”

INCITE’s industry partners, including Indianapolis-based Cook Regentec and West Lafayette-based Cook Biotech, plus the Lilly backing, boost Indy’s recruitment package. Shekhar says the companies are “also co-recruiting [the researchers], in a sense, as their partner; I think that adds twice the value for our scientists who come here.”

“This is an autocatalytic process, where each recruitment facilitates the next, and we’re building a great set of teams here in Indy and throughout the state,” says Weiss, who also sees the value of working closely with industry. “The commercialization process is the only way to get from an academic lab or hospital to patients. And the resources required to go through Phase 1, 2, 3, clinical trials and, ultimately, FDA approval of a new drug, are not the forte of the academic world, but requires a commercialization partner.”

Shekhar says those academic and industry relationships will create economic and commercial ripple effects.

“Every one of these recruits is going to create one or two companies with multiple commercializable ideas. It’s going to, essentially, make us a powerhouse in innovation and commercialization,” says Shekhar. “That dimension will probably take about a decade to fully mature, but it’s going to be a long-lasting legacy beyond the medical research.”

Both Shekhar and Weiss point to 16 Tech as fertile soil for startups; the 60-acre innovation community in Indianapolis is in close proximity to IUSM and Riley. Weiss co-founded Thermalin Diabetes, Inc. in a Cleveland Clinic incubator and is “excited to explore if we can move part of the company to 16 Tech and have a branch and labs in Indy.”

“The prospect of having incubators located near IUSM in Indy is exciting. 16 Tech can do for Indy and its economic vitalization what the biotech spinoffs have done around Purdue—the whole cluster in the electronics/engineering space. Here in Indianapolis, we have the potential for exciting growth and job creation in biotech,” says Weiss. “It’s two birds with one stone; we enhance the academic strength of IU, and we also contribute to job creation in Indy. That’s a great vision that combines our academic leadership with our civic leadership.”

Weiss says Indiana is working to strengthen its ability to attract early-stage funding.
Weiss believes the PHI will add momentum to the discovery process, which will lead to the creation of startups and partnerships with major companies.
Shekhar says the heavy involvement of industry partners is creating value for Indianapolis.
  • Perspectives

    • Richardson is a practice lead with Centric Consulting.

      How to Create Consistent and Positive Customer Experiences with Your Brand

      Everyone knows that keeping the consumer happy is the first priority. The importance of considering the customer’s experience in all areas of engaging with your business, not just customer service is becoming even more clear. I’m seeing an increasing number of my peers in the marketing world take ownership of the customer experience with their brands. As a result, we’re all learning how to borrow and...



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • (image courtesy of The Times of Northwest Indiana)

      U.S. Steel Updates Layoff Notice to State

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has updated the State of Indiana regarding its previously announced layoffs at the East Chicago Tin Mill. The company says 314, rather than 307, workers will be displaced when the mill is idled this fall. 

    • Red Star announced plans to expand and add 18 jobs.

      Larwill Medical Device Maker to Expand, Add Jobs

      A Whitley County-based medical device maker has announced plans to expand its facility in Larwill which should mean new jobs. Red Star Contract Manufacturing Inc. says it will invest $1.6 million in real estate improvements and additional equipment and will create 18 new jobs by 2022. 

    • Regal Beloit is closing in Valparaiso. (photo courtesy; The Times of Northwest Indiana)

      Valpo Bearings Plant to Close, Eliminating 160+ Jobs

      Wisconsin-based Regal Beloit Corp. and the union representing workers have reached an agreement about the closing of a helicopter bearing factory in Valparaiso. According to our partners at The Times of Northwest Indiana, the decision will cost between 160 to 170 workers their jobs. 

    • (WISH-TV Photo)

      Clif Bar Expands Indy Bakery

      California-based Clif Bar & Co. has completed a $10 million expansion of its commercial bakery in Indianapolis. The company says the project involved a more sustainable redesign of the facility for its employee-owners with a greater focus on energy efficiency.

    • Bob Stutz

      New Role For Salesforce Exec

      After three years on the job, Salesforce Marketing Cloud Chief Executive Officer Bob Stutz is moving into a new role. Stutz, who will remain in Indianapolis, is now executive vice president of strategic partners at Salesforce (NYSE: CRM).  Since arriving in Indianapolis, Stutz has overseen the establishment of the company’s regional headquarters in downtown Indianapolis, which included the Salesforce name being placed atop the state’s tallest building.